NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,475,000 | +33.7% | 51,600 | +67.3% | 0.78% | +81.6% |
| Q4 2019 | $2,599,000 | -39.3% | 30,847 | -75.9% | 0.43% | -52.2% |
| Q4 2018 | $4,285,000 | -61.9% | 127,973 | -40.3% | 0.90% | -51.1% |
| Q3 2018 | $11,236,000 | +43.2% | 214,431 | -14.5% | 1.84% | +38.2% |
| Q2 2018 | $7,849,000 | – | 250,769 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |